Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02936102
Title A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | FRA | ESP | CAN

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Ctr . New York New York 10065 United States Details
UT MD Anderson Cancer Center Houston Texas 77030 United States Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Koto ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field